跳至主要内容
临床试验/NCT06215547
NCT06215547Enrolling By Invitation不适用

Medtronic Enterra II Neurostimulator

Methodist Health System2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2015年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
500
试验地点
2
主要终点
Treating Self Reported Nausea and Vomiting using Enterra II during procedure

研究概览

简要总结

Humanitarian Device: Authorized by Federal (U.S.A.) Law for use in treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology.

详细描述

Description The Medtronic Enterra II Model 37800 Neurostimulator is a programmable device designed to deliver therapy through gastric electrical stimulation when connected to a lead system.

These components comprise the implantable portion of the Medtronic Enterra II system.

The operation of the neurostimulator is supported by a clinician programmer. The neurostimulator (Figure 1) operates on a sealed battery and electronic circuitry to provide controlled electrical pulse stimulation, through the implanted lead system.

A wide range of noninvasively programmable parameters and stimulation modes are available. The neurostimulator provides current parameter information, via telemetry, when used with the clinician programmer.

System Components

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years.

排除标准

  • Organ transplant
  • Organic obstruction
  • Pseudo-obstruction
  • Prior gastric surgery
  • Scleroderma
  • Amyloidosis
  • History of seizures
  • Peritoneal or unstable dialysis
  • Chemical dependency
  • Pregnancy
  • Primary eating or swallowing disorders
  • Psychogenic vomiting
  • Implanted electronic medical devices
  • Age < 18 or > 70 years

结局指标

主要结局

Treating Self Reported Nausea and Vomiting using Enterra II during procedure

时间窗: Up to 30 days

Using Enterra II system to prevent self reported Nausea and vomiting during a procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验